Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 31.3% from a year ago
Cash & equivalents stood at $111.45M at the end of Q2 FY2026, down 31.3% from a year earlier and down 24.8% from the prior quarter. Over 3 fiscal years it compounded at +30.1% a year.
Context
- Cash & equivalents amounted to 5.8% of total assets at the end of Q2 FY2026, down 7.0 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -31.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 167.61M USD
- Year-over-year change
- +110.7%
- 3-year CAGR
- +30.1%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 167.61M | +110.7% |
| FY2024 | 2024-12-31 | 79.55M | +76.4% |
| FY2023 | 2023-12-31 | 45.1M | -40.7% |
| FY2022 | 2022-12-31 | 76.09M | — |
Cash & Equivalents vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 cash & equivalents of $111.45M is the 6th highest of the 7 companies compared; the peer median is $1.7B.
- Its year-over-year change of -31.3% is the lowest of 7, against a peer median of +55.8%.
- Cash & equivalents amounts to 5.8% of total assets for ALAB, versus a peer median of 10.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $4.21B | +27.2% | +1.9% | 11.4% | |
| Aug 2026 | $3.93B | +221.2% | +42.5% | 14.3% | |
| Aug 2026 | $2.17B | -6.7% | +19.3% | 4.5% | |
| Jun 2026 | $1.24B | +84.4% | +4.9% | 4.8% | |
| Aug 2026 | $466.87M | +112.6% | +120.6% | 15.5% | |
| Jun 2026 | $111.45M | -31.3% | +30.1% | 5.8% | |
| Sep 2026 | $81.09M | -28.4% | -26.7% | 8.8% | |
| Peer median (excluding ALAB) | $1.7B | +55.8% | +12.1% | 10.1% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.